McAvoy David R.
SEC CIK 1758842 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | EVP, CLO | 13.0K | $21.0K | $76.2K | 3 | 2025-03-04 | 2025-09-05 |
Most active insiders at TEVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Francis Richard D | Pres, CEO | — | $31.26M |
| 2 | MIGNONE ROBERTO | Dir | — | $22.82M |
| 3 | Kalif Eliyahu Sharon | EVP, CFO | — | $20.72M |
| 4 | Sabag Mark | See "Remarks" | — | $13.15M |
| 5 | Daniell Richard | EVP, European Commercial | — | $12.08M |
| 6 | Hughes Eric A | See "Remarks" | — | $4.17M |
| 7 | Fox Christine | EVP, U.S. Commercial | — | $2.75M |
| 8 | Lippman Evan | EVP, Business Development | — | $2.16M |
| 9 | Weiss Amir | CAO | — | $1.41M |
| 10 | Shields Matthew | EVP, Gbl Ops | — | $1.40M |
McAvoy David R. made no open-market trades at TEVA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-09 | 2025-09-05 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McAvoy David R. | EVP, CLO | P - Purchase | $18.86 | +1,113 | 13.0K | +9% | +$21.0K | |
| DT | 2025-03-06 | 2025-03-04 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McAvoy David R. | EVP, CLO | M - OptEx | — | +16.7K | 16.7K | New | — |
| DMT | 2025-03-06 | 2025-03-04+ | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | McAvoy David R. | EVP, CLO | S - Sale+OE | $15.79 | -4,827 | 13.6K | -26% | -$76.2K |
Purchase Sale Sale after option exercise All abbreviations